PCSK9 and breast carcinoma: However, the results showed no significant relationship between genetically determined inhibition of PCSK9 and the risk of breast cancer, although there was a trend of reduced risk of breast cancer (OR: 0.92; 95% CI 0.86–0.98; P = 0.01).